Home

Paul T Quinlan

CIK 1333277 · General Counsel · last filed 2026-06-15

Paul T Quinlan is a General Counsel who has filed 76 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing shows the insider sold $51.1K of ORKA on Jun 15, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.81M

Companies

3

Total Filings

76

Lifetime Open-Market Net

-$1.64M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORKA General Counsel 31,034 $90.45 $2.81M -$81.4K 4 2026-06-15
CymaBay Therapeutics, Inc. (CBAY) Delisted General Counsel 0 $32.48 $0 -$1.50M 18 2024-03-22
TerraVia Holdings, Inc. (TVIA) Delisted General Counsel 218,403 — — -$58.2K 5 2017-03-13

Recent Filings

76 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 ORKA Sell (S) −733 -$51.1K EDGAR
2026-03-17 ORKA Sell (S) −733 -$30.3K EDGAR
2026-01-23 ORKA Grant (A) +32,500 $0 EDGAR
2025-01-24 ORKA Grant (A) — $0 EDGAR
2024-03-22 CymaBay Therapeutics, Inc. (CBAY) Delisted Disp (D) −70,262 $0 EDGAR
2024-03-15 CymaBay Therapeutics, Inc. (CBAY) Delisted Exer (M) +41,824 $330.0K EDGAR
2024-01-26 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) +28,438 $0 EDGAR
2024-01-16 — Notice (144) −5,000 -$117.9K EDGAR
2024-01-16 CymaBay Therapeutics, Inc. (CBAY) Delisted Mixed — -$103.2K EDGAR
2023-12-15 — Notice (144) −5,000 -$109.9K EDGAR
Showing 1–10 of 76
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.